Literature DB >> 7582499

Effects of BRL55834 in rat portal vein and bovine trachea: evidence for the induction of a glibenclamide-resistant, ATP-sensitive potassium current.

G Edwards1, J Schneider, A Niederste-Hollenberg, T Noack, A H Weston.   

Abstract

1. The effects of the benzopyran K-channel opener, BRL55834, on mechanical activity in bovine trachealis and rat portal vein were studied together with membrane currents in freshly-isolated single cells derived from these tissues. 2. BRL55834 (3 nM-1 microM) produced a concentration-dependent relaxation of bovine trachealis precontracted with 100 microM histamine and reduced the spontaneous mechanical activity of rat portal veins, effects which were antagonized by glibenclamide (1-10 microM) but were not reversible on washing. In contrast, charybdotoxin (250 nM) did not modify the spasmolytic effect of BRL55834 in bovine trachealis. 3. BRL55834 (10 nM-10 microM) did not relax segments of bovine trachealis precontracted with 80 mM KCl. 4. In some freshly-isolated single cells from bovine trachealis held at -10 mV, BRL55834 (3 microM) induced a time-independent outward K-current which was partially resistant to inhibition by glibenclamide (10 microM). In other cells, a very noisy, outwardly-rectifying and charybdotoxin-sensitive current developed in the presence of BRL55834 (3 microM) and in time-matched control cells. 5. In freshly-isolated single cells from rat portal vein held at -10 mV, BRL55834 (3 microM) induced a time- and calcium-independent outward K-current which was partially resistant (approximately 25% inhibition at +40 mV) to subsequent inhibition by glibenclamide (10 microM). In contrast, levcromakalim induced a time-independent outward K-current which was completely inhibited by glibenclamide 10 microM. 6. With the non-hydrolysable ATP analogue, AMP-PCP (5 mM), in the pipette, the ability of BRL55834 to induce a time-independent K-current in portal vein cells was markedly reduced (approximately 80% inhibition at +40 mV) whereas the effects of 10 microM levcromakalim were totally inhibited. 7. The glibenclamide-resistant current component induced by BRL55834 was totally inhibited by phentolamine (100 microM), a concentration that had no effect on the peak current (IBK(Ca)) induced by NS1619 (33 microM). 8. Stationary fluctuation analysis of the noise associated with the glibenclamide-insensitive K-current induced by BRL55834 in rat portal vein cells indicated that the unitary current flowing through the underlying channels was 0.26 pA at -10 mV, a value inconsistent with the involvement of BKCa. 9. It is concluded that the relaxations of both bovine trachea and rat portal vein produced by BRL55834 are associated with the opening of K-channels. These are probably identical to the ATP-sensitive K-channel opened by levcromakalim, although the involvement of an additional K-channel cannot be excluded. The reduced sensitivity of the BRL55834-induced changes to glibenclamide and toAMP-PCP may result from avid binding of BRL55834 to its site of action.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582499      PMCID: PMC1909032          DOI: 10.1111/j.1476-5381.1995.tb15914.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Effects of cromakalim on neurally-mediated responses of guinea-pig tracheal smooth muscle.

Authors:  J F Burka; J L Berry; R W Foster; R C Small; A J Watt
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

Review 2.  Adenosine 5'-triphosphate-sensitive potassium channels.

Authors:  F M Ashcroft
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

3.  Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands.

Authors:  A Fabiato
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  Inhibition of delayed rectifier K(+)-current by levcromakalim in single intestinal smooth muscle cells: effects of cations and dependence on K(+)-flux.

Authors:  D McHugh; D J Beech
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

5.  Properties of the ATP-sensitive K+ current activated by levcromakalim in isolated pulmonary arterial myocytes.

Authors:  L H Clapp; A M Gurney; N B Standen; P D Langton
Journal:  J Membr Biol       Date:  1994-06       Impact factor: 1.843

6.  Cloning and functional expression of a rat heart KATP channel.

Authors:  M L Ashford; C T Bond; T A Blair; J P Adelman
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

7.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

8.  Evaluation of the novel potassium channel activator BRL 55834 as an inhaled bronchodilator in guinea-pigs and rats: comparison with levcromakalim and salbutamol.

Authors:  J R Arch; N E Bowring; D R Buckle
Journal:  Pulm Pharmacol       Date:  1994-04

9.  [Modulation of cholinergic neurotransmission by Ca(2+)-activated K channel and Na(+)-K(+)-ATPase in canine airway smooth muscle].

Authors:  E Tagaya; J Tamaoki; K Isono; K Takeyama; A Chiyotani; K Konno
Journal:  Arerugi       Date:  1994-01

10.  Levcromakalim-induced modulation of membrane potassium currents, intracellular calcium and mechanical activity in rat mesenteric artery.

Authors:  D N Criddle; I A Greenwood; A H Weston
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

View more
  2 in total

1.  Impaired function of coronary BK(Ca) channels in metabolic syndrome.

Authors:  Léna Borbouse; Gregory M Dick; Shinichi Asano; Shawn B Bender; U Deniz Dincer; Gregory A Payne; Zachary P Neeb; Ian N Bratz; Michael Sturek; Johnathan D Tune
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-11       Impact factor: 4.733

2.  Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery.

Authors:  P M Zygmunt; E D Högestätt
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.